Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-02-02 00:00:00 ET · period of report 2026-01-31 · accession 0001468316-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | 2026-01-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +5,208 | 93.2K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-01-31 | A | A | 5,208 | $0.00 | 93,228 | D | — | — | (F1) 1. Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024. |